91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Three-Generation Sequencing Balanced Translocation Breakpoint Detection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Three-Generation Sequencing Balanced Translocation Breakpoint Detection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID: 
PB509245462
Publication Date: 
September 30, 2024
Pages: 
80
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 3,950.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Pharmaceutical Manufacturing [2]
Healthcare [3]
Pharma & Healthcare [4]
Description: 

Three-generation sequencing balanced translocation breakpoint detection is a method used to identify the specific location of balanced chromosomal translocations and determine the potential genetic consequences of these translocations within a family over three generations.
This method typically involves sequencing the genomes of multiple family members over three generations, including the proband (the person with the translocation), their parents, and their grandparents. By analyzing the genome sequences of these individuals, researchers can identify the exact breakpoints of the translocation and determine if any genes or regulatory elements have been disrupted or relocated.
This type of analysis can be important for understanding the genetic basis of certain diseases or conditions that are associated with balanced chromosomal translocations, such as certain types of cancer and developmental disorders. It can also be useful for family planning purposes, as it can provide information on the risk of passing on the translocation to future generations.
The global market for Three-Generation Sequencing Balanced Translocation Breakpoint Detection was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Three-Generation Sequencing Balanced Translocation Breakpoint Detection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Three-Generation Sequencing Balanced Translocation Breakpoint Detection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Three-Generation Sequencing Balanced Translocation Breakpoint Detection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Three-Generation Sequencing Balanced Translocation Breakpoint Detection include Berry Genomics, Peking Jabrehoo Med Tech, JIAXUE GENE, GrandOmics, BGI, Illumina, Thermo Fisher Scientific and Qiagen, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Three-Generation Sequencing Balanced Translocation Breakpoint Detection, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Three-Generation Sequencing Balanced Translocation Breakpoint Detection by region & country, by Type, and by Application.
The Three-Generation Sequencing Balanced Translocation Breakpoint Detection market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Three-Generation Sequencing Balanced Translocation Breakpoint Detection.
Market Segmentation
By Company
Berry Genomics
Peking Jabrehoo Med Tech
JIAXUE GENE
GrandOmics
BGI
Illumina
Thermo Fisher Scientific
Qiagen
Segment by Type:
Whole-Genome Sequencing
Targeted Sequencing
Others
Segment by Application
Assisted Reproduction
Scientific Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Three-Generation Sequencing Balanced Translocation Breakpoint Detection manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Three-Generation Sequencing Balanced Translocation Breakpoint Detection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Three-Generation Sequencing Balanced Translocation Breakpoint Detection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Market Overview
1.1 Three-Generation Sequencing Balanced Translocation Breakpoint Detection Product Introduction
1.2 Global Three-Generation Sequencing Balanced Translocation Breakpoint Detection Market Size Forecast
1.3 Three-Generation Sequencing Balanced Translocation Breakpoint Detection Market Trends & Drivers
1.3.1 Three-Generation Sequencing Balanced Translocation Breakpoint Detection Industry Trends
1.3.2 Three-Generation Sequencing Balanced Translocation Breakpoint Detection Market Drivers & Opportunity
1.3.3 Three-Generation Sequencing Balanced Translocation Breakpoint Detection Market Challenges
1.3.4 Three-Generation Sequencing Balanced Translocation Breakpoint Detection Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Three-Generation Sequencing Balanced Translocation Breakpoint Detection Players Revenue Ranking (2023)
2.2 Global Three-Generation Sequencing Balanced Translocation Breakpoint Detection Revenue by Company (2019-2024)
2.3 Key Companies Three-Generation Sequencing Balanced Translocation Breakpoint Detection Manufacturing Base Distribution and Headquarters
2.4 Key Companies Three-Generation Sequencing Balanced Translocation Breakpoint Detection Product Offered
2.5 Key Companies Time to Begin Mass Production of Three-Generation Sequencing Balanced Translocation Breakpoint Detection
2.6 Three-Generation Sequencing Balanced Translocation Breakpoint Detection Market Competitive Analysis
2.6.1 Three-Generation Sequencing Balanced Translocation Breakpoint Detection Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Three-Generation Sequencing Balanced Translocation Breakpoint Detection Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Three-Generation Sequencing Balanced Translocation Breakpoint Detection as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Whole-Genome Sequencing
3.1.2 Targeted Sequencing
3.1.3 Others
3.2 Global Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Type
3.2.1 Global Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value, by Type (2019-2030)
3.2.3 Global Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Assisted Reproduction
4.1.2 Scientific Research
4.1.3 Others
4.2 Global Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Application
4.2.1 Global Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value, by Application (2019-2030)
4.2.3 Global Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Region
5.1.1 Global Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Region (2019-2024)
5.1.3 Global Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Region (2025-2030)
5.1.4 Global Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value, 2019-2030
5.2.2 North America Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value, 2019-2030
5.3.2 Europe Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value, 2019-2030
5.4.2 Asia Pacific Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value, 2019-2030
5.5.2 South America Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value, 2019-2030
5.6.2 Middle East & Africa Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value
6.3 United States
6.3.1 United States Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value, 2019-2030
6.3.2 United States Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value, 2019-2030
6.4.2 Europe Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value, 2019-2030
6.5.2 China Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Type (%), 2023 VS 2030
6.5.3 China Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value, 2019-2030
6.6.2 Japan Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value, 2019-2030
6.7.2 South Korea Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value, 2019-2030
6.8.2 Southeast Asia Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value, 2019-2030
6.9.2 India Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Type (%), 2023 VS 2030
6.9.3 India Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Berry Genomics
7.1.1 Berry Genomics Profile
7.1.2 Berry Genomics Main Business
7.1.3 Berry Genomics Three-Generation Sequencing Balanced Translocation Breakpoint Detection Products, Services and Solutions
7.1.4 Berry Genomics Three-Generation Sequencing Balanced Translocation Breakpoint Detection Revenue (US$ Million) & (2019-2024)
7.1.5 Berry Genomics Recent Developments
7.2 Peking Jabrehoo Med Tech
7.2.1 Peking Jabrehoo Med Tech Profile
7.2.2 Peking Jabrehoo Med Tech Main Business
7.2.3 Peking Jabrehoo Med Tech Three-Generation Sequencing Balanced Translocation Breakpoint Detection Products, Services and Solutions
7.2.4 Peking Jabrehoo Med Tech Three-Generation Sequencing Balanced Translocation Breakpoint Detection Revenue (US$ Million) & (2019-2024)
7.2.5 Peking Jabrehoo Med Tech Recent Developments
7.3 JIAXUE GENE
7.3.1 JIAXUE GENE Profile
7.3.2 JIAXUE GENE Main Business
7.3.3 JIAXUE GENE Three-Generation Sequencing Balanced Translocation Breakpoint Detection Products, Services and Solutions
7.3.4 JIAXUE GENE Three-Generation Sequencing Balanced Translocation Breakpoint Detection Revenue (US$ Million) & (2019-2024)
7.3.5 GrandOmics Recent Developments
7.4 GrandOmics
7.4.1 GrandOmics Profile
7.4.2 GrandOmics Main Business
7.4.3 GrandOmics Three-Generation Sequencing Balanced Translocation Breakpoint Detection Products, Services and Solutions
7.4.4 GrandOmics Three-Generation Sequencing Balanced Translocation Breakpoint Detection Revenue (US$ Million) & (2019-2024)
7.4.5 GrandOmics Recent Developments
7.5 BGI
7.5.1 BGI Profile
7.5.2 BGI Main Business
7.5.3 BGI Three-Generation Sequencing Balanced Translocation Breakpoint Detection Products, Services and Solutions
7.5.4 BGI Three-Generation Sequencing Balanced Translocation Breakpoint Detection Revenue (US$ Million) & (2019-2024)
7.5.5 BGI Recent Developments
7.6 Illumina
7.6.1 Illumina Profile
7.6.2 Illumina Main Business
7.6.3 Illumina Three-Generation Sequencing Balanced Translocation Breakpoint Detection Products, Services and Solutions
7.6.4 Illumina Three-Generation Sequencing Balanced Translocation Breakpoint Detection Revenue (US$ Million) & (2019-2024)
7.6.5 Illumina Recent Developments
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Profile
7.7.2 Thermo Fisher Scientific Main Business
7.7.3 Thermo Fisher Scientific Three-Generation Sequencing Balanced Translocation Breakpoint Detection Products, Services and Solutions
7.7.4 Thermo Fisher Scientific Three-Generation Sequencing Balanced Translocation Breakpoint Detection Revenue (US$ Million) & (2019-2024)
7.7.5 Thermo Fisher Scientific Recent Developments
7.8 Qiagen
7.8.1 Qiagen Profile
7.8.2 Qiagen Main Business
7.8.3 Qiagen Three-Generation Sequencing Balanced Translocation Breakpoint Detection Products, Services and Solutions
7.8.4 Qiagen Three-Generation Sequencing Balanced Translocation Breakpoint Detection Revenue (US$ Million) & (2019-2024)
7.8.5 Qiagen Recent Developments
8 Industry Chain Analysis
8.1 Three-Generation Sequencing Balanced Translocation Breakpoint Detection Industrial Chain
8.2 Three-Generation Sequencing Balanced Translocation Breakpoint Detection Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Three-Generation Sequencing Balanced Translocation Breakpoint Detection Sales Model
8.5.2 Sales Channel
8.5.3 Three-Generation Sequencing Balanced Translocation Breakpoint Detection Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned: 

Berry Genomics
Peking Jabrehoo Med Tech
JIAXUE GENE
GrandOmics
BGI
Illumina
Thermo Fisher Scientific
Qiagen

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/three-generation-sequencing-balanced-translocation-breakpoint-detection-global-market-share

Links
[1] /countries/global[2] /pharmaceutical-manufacturing[3] /healthcare[4] /pharma-healthcare